Loading...
Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
Sorafenib exerts modest antitumor activity in patients with advanced hepatocellular carcinoma (HCC), and radiological progressive disease (rPD) does not always correspond to so-called clinical progressive disease (cPD). We evaluated 101 patients who initiated sorafenib treatment for HCC and assessed...
Saved in:
| Published in: | Diseases |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5548234/ https://ncbi.nlm.nih.gov/pubmed/28943609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases3020068 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|